RainMed group are excited to announce that, our CAFFR FlashAngio FFR Measurement System are going to launch the market and available for the customers. Prof. Huo, the inventor of this innovative technology, will deliver the launch related to the product at the 30th Great Wall Congress of Cardiology (GW-ICC) which will be held in Beijing, China from October 10th to13th.

The FlashAngio, which has 95% accuracy and 91% FFR values between 0.75-0.85 cut-off zone, is so far the most accurate CFD-based FFR product correlating to FFR. The clinical trial conducted in six centers regarding the comparison between CAFFR and FFR will be published soon.

We will have a kick-off of a new project of the follow-up monitor clinical trial like FAME II regarding CAFFR guided PCI and other treatment in WG-ICC. We have now 20 sites registered and  are still enrolling. We would also like to share more information and further plans about the trail on WG-ICC.

Please join us in this great event, feel free to contact our local partners for more details if you are interested. We are glad to have this cut-edge technology and hope it can benefit doctors, patients and healthcare financial system in the future.

Find more information about RainMed and FlashAngio System on our official website: www.rainmed.com